Right on cue...
Bret Jensen via Seeking Alpha had a "short serving" flawed opinion piece at the ready for the next ADXS good news release which came this morning. Titled Advaxis: Worthy of a Tepid Thumbs Up. He suggested part of his "damn 'em with faint praise" approach is because there's been a lot of management turnover and insiders haven't been buying since 2015. A couple of high level folks have left but turnover doesn't appear to be out of the normal for a small developmental biotech. On his second concern, ADXS leadership buys every month as is reflected in the company presentation he obviously didn't read.
He does say he is holding a small number of shares. Truth be told, I'm guessing he has far more shares borrowed and shorted.
I dumped my Seeking Alpha subscription after the Richard Pearson hatchet job on ADXS in January 2015. I have absolutely no confidence in Seeking Alpha's agenda nor their authors objectivity, accuracy or motives.
G.B.